NSABP FB-10: Phase Ib dose-escalation trial evaluating trastuzumab emtansine (T-DMI) with neratinib (N) in women with metastatic HER2+breast cancer (MBC)

Category Primary study
JournalCANCER RESEARCH
Year 2017
This article has no abstract
Epistemonikos ID: 3954d6b949a6e3ca12e9829d0bea64f2439f9f67
First added on: Feb 08, 2025